270 related articles for article (PubMed ID: 30685456)
1. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis.
Zhou L; Leonard A; Pavel AB; Malik K; Raja A; Glickman J; Estrada YD; Peng X; Del Duca E; Sanz-Cabanillas J; Ruano J; Xu H; Zhang N; Wen HC; Gonzalez J; Garcet S; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Jul; 144(1):144-156. PubMed ID: 30685456
[TBL] [Abstract][Full Text] [Related]
2. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.
He H; Del Duca E; Diaz A; Kim HJ; Gay-Mimbrera J; Zhang N; Wu J; Beaziz J; Estrada Y; Krueger JG; Pavel AB; Ruano J; Guttman-Yassky E
J Allergy Clin Immunol; 2021 Apr; 147(4):1369-1380. PubMed ID: 33011244
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
4. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
5. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
[TBL] [Abstract][Full Text] [Related]
6. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.
Renert-Yuval Y; Del Duca E; Pavel AB; Fang M; Lefferdink R; Wu J; Diaz A; Estrada YD; Canter T; Zhang N; Wagner A; Chamlin S; Krueger JG; Guttman-Yassky E; Paller AS
J Allergy Clin Immunol; 2021 Jul; 148(1):148-163. PubMed ID: 33453290
[TBL] [Abstract][Full Text] [Related]
7. Atopic dermatitis in African American patients is T
Sanyal RD; Pavel AB; Glickman J; Chan TC; Zheng X; Zhang N; Cueto I; Peng X; Estrada Y; Fuentes-Duculan J; Alexis AF; Krueger JG; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2019 Jan; 122(1):99-110.e6. PubMed ID: 30223113
[TBL] [Abstract][Full Text] [Related]
8. Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients.
Lang CCV; Renert-Yuval Y; Del Duca E; Pavel AB; Wu J; Zhang N; Dubin C; Obi A; Chowdhoury M; Kim M; Estrada YD; Krueger JG; Kaderbhai H; Semango G; Schmid-Grendelmeier P; Brüggen MC; Masenga JE; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2021 Sep; 127(3):334-341. PubMed ID: 33975024
[TBL] [Abstract][Full Text] [Related]
9. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
[TBL] [Abstract][Full Text] [Related]
10. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
[TBL] [Abstract][Full Text] [Related]
11. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
Guttman-Yassky E; Diaz A; Pavel AB; Fernandes M; Lefferdink R; Erickson T; Canter T; Rangel S; Peng X; Li R; Estrada Y; Xu H; Krueger JG; Paller AS
JAMA Dermatol; 2019 Dec; 155(12):1358-1370. PubMed ID: 31596431
[TBL] [Abstract][Full Text] [Related]
12. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.
Suárez-Fariñas M; Ungar B; Noda S; Shroff A; Mansouri Y; Fuentes-Duculan J; Czernik A; Zheng X; Estrada YD; Xu H; Peng X; Shemer A; Krueger JG; Lebwohl MG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1277-87. PubMed ID: 26316095
[TBL] [Abstract][Full Text] [Related]
13. Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis.
He H; Bissonnette R; Wu J; Diaz A; Saint-Cyr Proulx E; Maari C; Jack C; Louis M; Estrada Y; Krueger JG; Zhang N; Pavel AB; Guttman-Yassky E
J Allergy Clin Immunol; 2021 Jan; 147(1):199-212. PubMed ID: 32709423
[TBL] [Abstract][Full Text] [Related]
14. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
[TBL] [Abstract][Full Text] [Related]
15. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
[TBL] [Abstract][Full Text] [Related]
16. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
Brunner PM; Pavel AB; Khattri S; Leonard A; Malik K; Rose S; Jim On S; Vekaria AS; Traidl-Hoffmann C; Singer GK; Baum D; Gilleaudeau P; Sullivan-Whalen M; Fuentes-Duculan J; Li X; Zheng X; Estrada Y; Garcet S; Wen HC; Gonzalez J; Coats I; Cueto I; Neumann AU; Lebwohl MG; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Jan; 143(1):142-154. PubMed ID: 30121291
[TBL] [Abstract][Full Text] [Related]
17. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
[TBL] [Abstract][Full Text] [Related]
18. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type.
Kabashima-Kubo R; Nakamura M; Sakabe J; Sugita K; Hino R; Mori T; Kobayashi M; Bito T; Kabashima K; Ogasawara K; Nomura Y; Nomura T; Akiyama M; Shimizu H; Tokura Y
J Dermatol Sci; 2012 Jul; 67(1):37-43. PubMed ID: 22591815
[TBL] [Abstract][Full Text] [Related]
19. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.
Guttman-Yassky E; Pavel AB; Zhou L; Estrada YD; Zhang N; Xu H; Peng X; Wen HC; Govas P; Gudi G; Ca V; Fang H; Salhi Y; Back J; Reddy V; Bissonnette R; Maari C; Grossman F; Wolff G
J Allergy Clin Immunol; 2019 Aug; 144(2):482-493.e7. PubMed ID: 30738171
[TBL] [Abstract][Full Text] [Related]
20. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.
Correa da Rosa J; Malajian D; Shemer A; Rozenblit M; Dhingra N; Czarnowicki T; Khattri S; Ungar B; Finney R; Xu H; Zheng X; Estrada YD; Peng X; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Mar; 135(3):712-20. PubMed ID: 25583101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
